Importance of m N6-methyladenosine (m6A) RNA modification in cancer

被引:0
|
作者
Gulten Tuncel
Rasime Kalkan
机构
[1] Near East University,Department of Molecular Medicine, Faculty of Medicine
[2] Near East University,Department of Medical Genetics, Faculty of Medicine
来源
Medical Oncology | 2019年 / 36卷
关键词
RNA methylation; N6-methyladenosine (m6A); Cancer; Epigenetics;
D O I
暂无
中图分类号
学科分类号
摘要
RNA methylation, which was identified back in 1970s, has gained remarkable interest in recent years as it was shown to be a reversible modification involved in many cellular processes like mRNA and miRNA processing, mRNA localisation, translation suppression, or activation. These, in turn, affect important bioprocesses such as tissue development, sex determination, and DNA damage response. Important group of proteins are responsible for adding, recognizing, and removing the methyl group to and from the RNA molecules, which are referred as writers, readers, and erasers, respectively. If any of the processes is not strictly controlled, this can cause abnormalities in gene expression, which result in diseases including cancers such as lung, pancreas, glioblastoma, and breast cancer. Mechanisms of RNA methylation and its role in various cancer types and diagnostic methods for RNA methylation are discussed in this article.
引用
收藏
相关论文
共 50 条
  • [31] N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases
    Tan, Man
    Liu, Siyi
    Liu, Lubin
    CLINICAL EPIGENETICS, 2024, 16 (01)
  • [32] Obesity specific N6-methyladenosine (m6A) RNA modification in human adipose tissue
    Ronningen, T.
    Zeng, Y.
    Visnovska, M.
    Dahl, M. B.
    Wang, J.
    Poulsen, L. la Cour
    Kristinsson, J. A.
    Mala, T.
    Hertel, J. K.
    Hjelmesaeth, J.
    Valderhaug, T. G.
    He, H. H.
    Bottcher, Y.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S34 - S34
  • [33] RNA N6-methyladenosine (m6A) modification in HNSCC: molecular mechanism and therapeutic potential
    Sun, Xinyu
    Fu, Shengqiao
    Yuan, Xiao
    Pu, Xi
    Wang, RunKun
    Wang, Xu
    Lu, Hanqiang
    CANCER GENE THERAPY, 2023, 30 (09) : 1209 - 1214
  • [34] Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment
    Wang, Dan
    Han, Yingying
    Peng, Lushan
    Huang, Tao
    He, Xiaoyun
    Wang, Junpu
    Ou, Chunlin
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (07): : 2198 - 2219
  • [35] N6-methyladenosine (m6A) RNA modification in the pathophysiology of heart failure: a narrative review
    Liu, Sihan
    Wang, Tongyu
    Cheng, Zeyi
    Liu, Jing
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2022, 12 (06) : 908 - 925
  • [36] RNA N6-methyladenosine (m6A) modification in HNSCC: molecular mechanism and therapeutic potential
    Xinyu Sun
    Shengqiao Fu
    Xiao Yuan
    Xi Pu
    RunKun Wang
    Xu Wang
    Hanqiang Lu
    Cancer Gene Therapy, 2023, 30 : 1209 - 1214
  • [37] N6-methyladenosine (m6A)RNAmodification in cancer stem cells
    Ma, Zhonghua
    Ji, Jiafu
    STEM CELLS, 2020, 38 (12) : 1511 - 1519
  • [38] The crucial roles of N6-methyladenosine (m6A) modification in the carcinogenesis and progression of colorectal cancer
    Fang, Zhihao
    Hu, Yiqiu
    Hu, Jinhui
    Huang, Yanqin
    Zheng, Shu
    Guo, Cheng
    CELL AND BIOSCIENCE, 2021, 11 (01):
  • [39] The crucial roles of N6-methyladenosine (m6A) modification in the carcinogenesis and progression of colorectal cancer
    Zhihao Fang
    Yiqiu Hu
    Jinhui Hu
    Yanqin Huang
    Shu Zheng
    Cheng Guo
    Cell & Bioscience, 11
  • [40] N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications
    Hu, Bin-bin
    Wang, Xiao-yan
    Gu, Xu-Yu
    Zou, Chen
    Gao, Zhen-jun
    Zhang, Heng
    Fan, Yu
    MOLECULAR CANCER, 2019, 18 (01)